NEW YORK – Meridian Bioscience announced Thursday its preliminary revenues for the first quarter of fiscal year 2021 were up 94 percent compared to the previous year, driven largely by an increase in the firm's life science segment.
NEW YORK – Meridian Bioscience announced Thursday its preliminary revenues for the first quarter of fiscal year 2021 were up 94 percent compared to the previous year, driven largely by an increase in the firm's life science segment.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.